We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTHM icon
13676
PUT
Fathom Holdings
FTHM
$25M
$2.04K ﹤0.01%
+500
New +$3.24K
SPNT icon
13677
PUT
SiriusPoint
SPNT
$2.76B
$2.03K ﹤0.01%
+200
New +$2K
DTIL icon
13678
CALL
Precision BioSciences
DTIL
$205M
$2.01K ﹤0.01%
197
-113
-36% -$1.74K
LODE icon
13679
PUT
Comstock
LODE
$263M
$2.01K ﹤0.01%
490
-120
-20% -$623
BCDA icon
13680
PUT
BioCardia
BCDA
$14.5M
$2.01K ﹤0.01%
313
-780
-71% -$13.1K
ATOM icon
13681
Atomera
ATOM
$219M
$2K ﹤0.01%
320
-16,509
-98% -$118K
IRAAW
13682
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$1.99K ﹤0.01%
49,749
-128,555
-72% -$4.83K
PPYAW
13683
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$1.99K ﹤0.01%
35,866
+3,973
+12% +$265
HLTH
13684
DELISTED
Cue Health Inc. Common Stock
HLTH
$1.98K ﹤0.01%
+4,472
New +$2.04K
HARP
13685
CALL
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1.98K ﹤0.01%
490
+440
+880% +$3.26K
ADCT icon
13686
CALL
ADC Therapeutics
ADCT
$128M
$1.97K ﹤0.01%
2,200
+1,900
+633% +$2.53K
XPER icon
13687
PUT
Xperi
XPER
$329M
$1.97K ﹤0.01%
200
CETUW
13688
DELISTED
Cetus Capital Acquisition Corp. Warrant
CETUW
$1.96K ﹤0.01%
73,141
+12,875
+21% +$798
PPTA
13689
CALL
Perpetua Resources
PPTA
$3.16B
$1.96K ﹤0.01%
600
+500
+500% +$1.75K
MITAW
13690
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$1.95K ﹤0.01%
+15,978
New +$2.44K
NXTC icon
13691
CALL
NextCure
NXTC
$37.6M
$1.94K ﹤0.01%
125
BHACW
13692
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$1.92K ﹤0.01%
34,909
+13,855
+66% +$438
LGHLW
13693
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$1.91K ﹤0.01%
201,083
+92,662
+85% +$1.05K
FATE icon
13694
CALL
Fate Therapeutics
FATE
$300M
$1.91K ﹤0.01%
900
-8,000
-90% -$26.5K
NFBK
13695
CALL
DELISTED
Northfield Bancorp
NFBK
$1.89K ﹤0.01%
200
-100
-33% -$1.09K
NFBK
13696
PUT
DELISTED
Northfield Bancorp
NFBK
$1.89K ﹤0.01%
200
-2,600
-93% -$28.4K
CELU icon
13697
CALL
Celularity
CELU
$20.1M
$1.89K ﹤0.01%
850
ODVWW
13698
DELISTED
Osisko Development Corp. Warrant
ODVWW
$1.88K ﹤0.01%
+31,885
New +$64.2K
GORO icon
13699
CALL
Goldgroup Mining Inc.
GORO
$207M
$1.88K ﹤0.01%
+4,400
New +$2.35K
MNTX
13700
CALL
DELISTED
Manitex International, Inc.
MNTX
$1.87K ﹤0.01%
400

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.